Company / Profit Margin
Tvardi Therapeutics, Inc. Profit Margin History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-204.2%
FY2024
5-year range
-549.5% / 6.2%
FY2020-FY2024
Trend
+46.8%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has fluctuated over the past 10 years, ranging from -66604.7% in FY2018 to 6.2% in FY2022.
Based on SEC 10-K filings.
-204.2% in FY2024 with a 5-year CAGR of +6176.2%.
Declined from 6.2% to -204.2% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +330.8pp
- 5-Year Change
- +6176.2pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, profit margin increased 46.8% year-over-year.
- Peak profit margin was recorded in FY2022.
- Lowest profit margin in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -6.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -204.2% | +46.8% |
| FY2023 | -384.1% | -6264.7% |
| FY2022 | 6.2% | +101.2% |
| FY2021 | -534.9% | +2.7% |
| FY2020 | -549.5% | +91.4% |
| FY2019 | -6380.4% | +90.4% |
| FY2018 | -66604.7% | -10159.2% |
| FY2017 | -649.2% | -16.2% |
| FY2016 | -558.5% | -1586.4% |
| FY2015 | -33.1% | +93.7% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026